Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Building a new conceptual framework for receptor heteromers.

Ferré S, Baler R, Bouvier M, Caron MG, Devi LA, Durroux T, Fuxe K, George SR, Javitch JA, Lohse MJ, Mackie K, Milligan G, Pfleger KD, Pin JP, Volkow ND, Waldhoer M, Woods AS, Franco R.

Nat Chem Biol. 2009 Mar;5(3):131-4. doi: 10.1038/nchembio0309-131.

2.

Revolution in GPCR signalling: opioid receptor heteromers as novel therapeutic targets: IUPHAR review 10.

Fujita W, Gomes I, Devi LA.

Br J Pharmacol. 2014 Sep;171(18):4155-76. doi: 10.1111/bph.12798. Review.

3.

G protein-independent cell-based assays for drug discovery on seven-transmembrane receptors.

Verkaar F, van Rosmalen JW, Blomenröhr M, van Koppen CJ, Blankesteijn WM, Smits JF, Zaman GJ.

Biotechnol Annu Rev. 2008;14:253-74. doi: 10.1016/S1387-2656(08)00010-0. Review.

PMID:
18606367
4.

G-protein-coupled receptor type A heteromers as an emerging therapeutic target.

Guidolin D, Agnati LF, Marcoli M, Borroto-Escuela DO, Fuxe K.

Expert Opin Ther Targets. 2015 Feb;19(2):265-83. doi: 10.1517/14728222.2014.981155. Epub 2014 Nov 10. Review.

PMID:
25381716
5.

Molecular approaches to receptors as targets for drug discovery.

Herz JM, Thomsen WJ, Yarbrough GG.

J Recept Signal Transduct Res. 1997 Sep;17(5):671-776. Review.

PMID:
9292776
6.

Peptide-binding G protein-coupled receptors: new opportunities for drug design.

Gurrath M.

Curr Med Chem. 2001 Nov;8(13):1605-48. Review.

PMID:
11562281
7.

Nuclear hormone receptors as targets for new drug discovery.

McDonnell DP, Vegeto E, Gleeson MA.

Biotechnology (N Y). 1993 Nov;11(11):1256-61. Review.

PMID:
7764187
8.

The signal transduction model of carcinogenesis.

Schüller HM.

Biochem Pharmacol. 1991 Sep 27;42(8):1511-23. Review. No abstract available.

PMID:
1656987
9.

Prime time for G-protein-coupled receptor heteromers as therapeutic targets for CNS disorders: the dopamine D₁-D₃ receptor heteromer.

Ferré S, Lluis C, Lanciego JL, Franco R.

CNS Neurol Disord Drug Targets. 2010 Nov;9(5):596-600. Review.

PMID:
20632968
10.

Adenosine receptor heteromers and their integrative role in striatal function.

Ferré S, Ciruela F, Quiroz C, Luján R, Popoli P, Cunha RA, Agnati LF, Fuxe K, Woods AS, Lluis C, Franco R.

ScientificWorldJournal. 2007 Nov 2;7:74-85. Review.

11.

Antibodies to probe endogenous G protein-coupled receptor heteromer expression, regulation, and function.

Gomes I, Gupta A, Bushlin I, Devi LA.

Front Pharmacol. 2014 Dec 3;5:268. doi: 10.3389/fphar.2014.00268. eCollection 2014. Review.

12.

Receptor triggering and receptor regulation: structure-activity relationships from the receptor's point of view.

Hollenberg MD.

J Med Chem. 1990 May;33(5):1275-81. Review. No abstract available.

PMID:
2158558
13.

Receptor subtypes or species homologues: relevance to drug discovery.

Hall JM, Caulfield MP, Watson SP, Guard S.

Trends Pharmacol Sci. 1993 Oct;14(10):376-83. Review.

PMID:
8296394
14.

GPCR heteromers and their allosteric receptor-receptor interactions.

Fuxe K, Borroto-Escuela DO, Marcellino D, Romero-Fernandez W, Frankowska M, Guidolin D, Filip M, Ferraro L, Woods AS, Tarakanov A, Ciruela F, Agnati LF, Tanganelli S.

Curr Med Chem. 2012;19(3):356-63. Review.

PMID:
22335512
15.

Hormones and Neuropeptide Receptor Heteromers in the Ventral Tegmental Area. Targets for the Treatment of Loss of Control of Food Intake and Substance Use Disorders.

Ferré S.

Curr Treat Options Psychiatry. 2017;4(2):167-183. doi: 10.1007/s40501-017-0109-x. Epub 2017 Apr 22. Review.

16.

Functional relevance of neurotransmitter receptor heteromers in the central nervous system.

Ferré S, Ciruela F, Woods AS, Lluis C, Franco R.

Trends Neurosci. 2007 Sep;30(9):440-6. Epub 2007 Aug 10. Review.

PMID:
17692396
17.

G Protein-Coupled Receptor Heteromers.

Gomes I, Ayoub MA, Fujita W, Jaeger WC, Pfleger KD, Devi LA.

Annu Rev Pharmacol Toxicol. 2016;56:403-25. doi: 10.1146/annurev-pharmtox-011613-135952. Epub 2015 Oct 22. Review.

18.

Heteromers of μ-δ opioid receptors: new pharmacology and novel therapeutic possibilities.

Fujita W, Gomes I, Devi LA.

Br J Pharmacol. 2015 Jan;172(2):375-87. doi: 10.1111/bph.12663. Epub 2014 Jul 1. Review.

19.

G protein-coupled receptor heteromers as new targets for drug development.

Ferré S, Navarro G, Casadó V, Cortés A, Mallol J, Canela EI, Lluís C, Franco R.

Prog Mol Biol Transl Sci. 2010;91:41-52. doi: 10.1016/S1877-1173(10)91002-8. Review.

PMID:
20691958
20.

Novel pharmacological targets based on receptor heteromers.

Franco R, Casadó V, Cortés A, Pérez-Capote K, Mallol J, Canela E, Ferré S, Lluis C.

Brain Res Rev. 2008 Aug;58(2):475-82. doi: 10.1016/j.brainresrev.2008.06.002. Epub 2008 Jun 20. Review.

PMID:
18620000

Supplemental Content

Support Center